178
Views
53
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma

, , , , , , , & show all
Pages 279-283 | Received 29 Jul 2009, Accepted 26 Oct 2009, Published online: 28 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Meredith M. Nichols, Sarah L. Ondrejka, Sujata Patil, Lisa Durkin, Brian T. Hill & Eric D. Hsi. (2023) Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOP. Leukemia & Lymphoma 64:8, pages 1433-1441.
Read now
Xingchen Wu, Hannu Pertovaara, Pasi Korkola, Martine Vornanen, Ritva Järvenpää, Prasun Dastidar, Hannu Eskola & Pirkko-Liisa Kellokumpu-Lehtinen. (2014) Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma. Acta Oncologica 53:8, pages 1093-1099.
Read now
Yasumitsu Hirose, Hiroaki Suefuji, Hayato Kaida, Masanobu Hayakawa, Satoshi Hattori, Seiji Kurata, Yuko Watanabe, Yukiko Kunou, Akihiko Kawahara, Takashi Okamura, Koichi Ohshima, Masayoshi Kage, Masatoshi Ishibashi & Naofumi Hayabuchi. (2014) Relationship between 2-deoxy-2-[18F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:3, pages 520-525.
Read now
Xingchen Wu, Hannu Pertovaara, Pasi Korkola, Martine Vornanen, Hannu Eskola & Pirkko-Liisa Kellokumpu-Lehtinen. (2012) Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma. Leukemia & Lymphoma 53:3, pages 400-405.
Read now
Hélène Lanic, Sylvain Mareschal, Férial Mechken, Jean-Michel Picquenot, Marie Cornic, Catherine Maingonnat, Philippe Bertrand, Florian Clatot, Elodie Bohers, Aspasia Stamatoullas, Stéphane Leprêtre, Vinciane Rainville, Philippe Ruminy, Christian Bastard, Hervé Tilly, Stéphanie Becker, Pierre Vera & Fabrice Jardin. (2012) Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma. Leukemia & Lymphoma 53:1, pages 34-42.
Read now
Michael S. Hofman & Rodney J. Hicks. (2010) Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma. Leukemia & Lymphoma 51:2, pages 183-185.
Read now

Articles from other publishers (47)

Mahdi Zirakchian Zadeh. (2023) Clinical Application of 18F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 23:11, pages 800-814.
Crossref
Sofiullah Abubakar, Stuart More, Naima Tag, Afusat Olabinjo, Ahmed Isah & Ismaheel Lawal. (2023) Differences in Tumour Aggressiveness Based on Molecular Subtype and Race Measured by [18F]FDG PET Metabolic Metrics in Patients with Invasive Carcinoma of the Breast. Diagnostics 13:12, pages 2059.
Crossref
Katherine Cecil, Laura Huppert, Rita Mukhtar, Elizabeth H. Dibble, Sophia R. O’Brien, Gary A. Ulaner & Courtney Lawhn-Heath. (2023) Metabolic Positron Emission Tomography in Breast Cancer. PET Clinics.
Crossref
Ashley R. Paquin, Emmanuella Oyogoa, Hannah Stowe McMurry, Thomas Kartika, Malinda West & Joseph J. Shatzel. (2022) The diagnosis and management of suspected lymphoma in general practice. European Journal of Haematology 110:1, pages 3-13.
Crossref
Luca Ceriani & Emanuele Zucca. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging 370 386 .
Steven H. KroftCordelia E. SeverAdam BaggBrooke Billman, Catherine DiefenbachDavid M. DorfmanWilliam G. FinnDita A. GratzingerPatricia A. GreggJohn P. LeonardSonali SmithLesley Souter, Ronald L. WeissChristina B. Ventura & Matthew C. Cheung. (2021) Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists. Archives of Pathology & Laboratory Medicine 145:3, pages 269-290.
Crossref
Steven H Kroft, Cordelia E Sever, Adam Bagg, Brooke Billman, Catherine Diefenbach, David M Dorfman, William G Finn, Dita A Gratzinger, Patricia A Gregg, John P Leonard, Sonali Smith, Lesley Souter, Ronald L Weiss, Christina B Ventura & Matthew C Cheung. (2021) Laboratory Workup of Lymphoma in Adults. American Journal of Clinical Pathology 155:1, pages 12-37.
Crossref
Shelly Soffer, Marianne M. Amitai, Rony Weizen, Adam Retter, Iris Barshack, Orit Shimon, Tima Davidson & Eyal Klang. (2019) PET-CT imaging features that differentiate between positive and negative EWSR1 translocation in Ewing sarcoma. Nuclear Medicine Communications 40:8, pages 827-834.
Crossref
Hans-Jonas Meyer, Andreas Wienke & Alexey Surov. (2019) Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 19:6, pages e266-e272.
Crossref
Hongling Li, Xiaohuan Wang, Lingfang Zhang, Xuemei Yi, Yujie Qiao & Qianqian Jin. (2019) Correlations between maximum standardized uptake value measured via 18 F-fluorodeoxyglucose positron emission tomography/computed tomography and clinical variables and biochemical indicators in adult lymphoma . Journal of Cancer Research and Therapeutics 15:7, pages 1581.
Crossref
Tomoka Kitao, Tohru Shiga, Kenji Hirata, Mitsunori Sekizawa, Toshiki Takei, Katsushige Yamashiro & Nagara Tamaki. (2018) Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas. Annals of Nuclear Medicine 33:1, pages 22-31.
Crossref
Marius E. Mayerhoefer, Markus Raderer, Ulrich Jaeger, Philipp Staber, Barbara Kiesewetter, Daniela Senn, Ferdia A. Gallagher, Kevin Brindle, Edit Porpaczy, Michael Weber, Dominik Berzaczy, Ingrid Simonitsch-Klupp, Christian Sillaber, Cathrin Skrabs & Alexander Haug. (2018) Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment. European Journal of Nuclear Medicine and Molecular Imaging 45:6, pages 931-940.
Crossref
Ji Hyun Park, Shin Kim, Jin Sook Ryu, Sang-wook Lee, Chan-sik Park, Jooryung Huh & Cheolwon Suh. (2018) Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL). Hematological Oncology 36:1, pages 56-61.
Crossref
Tarec Christoffer El-Galaly, Lars Christian Gormsen & Martin Hutchings. (2018) PET/CT for Staging; Past, Present, and Future. Seminars in Nuclear Medicine 48:1, pages 4-16.
Crossref
Sally F. Barrington & Kent Friedman. 2018. PET/MRI in Oncology. PET/MRI in Oncology 373 400 .
Tamar Tadmor, Irena Liphshitz, Barbara Silverman & Aaron Polliack. (2017) Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up. Hematological Oncology 35:4, pages 599-607.
Crossref
Chin-Chuan Chang, Shih-Feng Cho, Hung-Pin Tu, Chia-Yang Lin, Ya-Wen Chuang, Shu-Min Chang, Wen-Ling Hsu & Ying-Fong Huang. (2017) Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy. Medicine 96:45, pages e8655.
Crossref
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/CT in the clinical management of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 312-321.
Crossref
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/TC en el manejo clínico de los linfomas. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 312-321.
Crossref
Huimin Lin, Guoyuan Yang, Bei Ding, Miao Zhang, Mingjun Zhang, Fuhua Yan, Ying Qu & Huan Zhang. (2017) Secreted frizzled-related protein 1 overexpression in gastric cancer: Relationship with radiological findings of dual-energy spectral CT and PET-CT. Scientific Reports 7:1.
Crossref
Chadwick L. Wright, Joseph J. Maly, Jun Zhang & Michael V. Knopp. (2017) Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma. PET Clinics 12:1, pages 63-82.
Crossref
Martina Urbani, Eugenio Borsatti & Tanja Baresic. 2017. Manual of Cardio-oncology. Manual of Cardio-oncology 397 405 .
G.A. Jiménez Londoño, A.M. García Vicente, V.M. Poblete García, M. Amo-Salas, C. Calle Primo, Á. Ibañez García, B. Martínez Sanchís, J.F. López-Fidalgo, F. Solano Ramos, A. Martínez Hellín, M. Díaz Morfa & Á. Soriano Castrejón. (2016) Basal 18 F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 35:5, pages 298-305.
Crossref
G.A. Jiménez Londoño, A.M. García Vicente, V.M. Poblete García, M. Amo-Salas, C. Calle Primo, Á. Ibañez García, B. Martínez Sanchís, J.F. López-Fidalgo, F. Solano Ramos, A. Martínez Hellín, M. Díaz Morfa & Á. Soriano Castrejón. (2016) Basal 18F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment. Revista Española de Medicina Nuclear e Imagen Molecular 35:5, pages 298-305.
Crossref
Honghui Huang, Fei Xiao, Xiaofeng Han, Lu Zhong, Hua Zhong, Lan Xu, Jianyi Zhu, Beiwen Ni, Jia Liu, Yi Fang, Minyue Zhang, Lijing Shen, Ting Wang, Jianjun Liu, Yiping Shi, Yumei Chen, Luying Zheng, Qiang Liu, Fangyuan Chen & Jianmin Wang. (2016) Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma. Nuclear Medicine Communications 37:7, pages 689-698.
Crossref
A.F. Scarsbrook & S.F. Barrington. (2016) PET-CT in the UK: current status and future directions. Clinical Radiology 71:7, pages 673-690.
Crossref
L. Valls, C. Badve, S. Avril, K. Herrmann, P. Faulhaber, J. O'Donnell & N. Avril. (2016) FDG-PET imaging in hematological malignancies. Blood Reviews 30:4, pages 317-331.
Crossref
S.F. Barrington, P. Fosse, N. Withofs, E. Itti, R. Hustinx, O.-F. Couturier & M. Meignan. (2016) Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire 40:1, pages 55-64.
Crossref
Chiara Lestuzzi, Antonino De Paoli, Tanja Baresic, Gianmaria Miolo & Angela Buonadonna. (2015) Malignant cardiac tumors: diagnosis and treatment. Future Cardiology 11:4, pages 485-500.
Crossref
Sheng-ming Deng, Wei Zhang, Bin Zhang, Yin-yin Chen, Ji-hui Li & Yi-wei Wu. (2015) Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis. PLOS ONE 10:6, pages e0129028.
Crossref
Marius E. Mayerhoefer, Georgios Karanikas, Kurt Kletter, Helmut Prosch, Barbara Kiesewetter, Cathrin Skrabs, Edit Porpaczy, Michael Weber, Thomas Knogler, Christian Sillaber, Ulrich Jaeger, Ingrid Simonitsch-Klupp, Philipp Ubl, Leonhard Müllauer, Werner Dolak, Julius Lukas & Markus Raderer. (2015) Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients. Clinical Cancer Research 21:11, pages 2506-2513.
Crossref
Aaron J. Fowler, Amanda L. Richer, Ross M. Bremner & Landon J. Inge. (2015) A high-fat diet is associated with altered adipokine production and a more aggressive esophageal adenocarcinoma phenotype in vivo. The Journal of Thoracic and Cardiovascular Surgery 149:4, pages 1185-1191.
Crossref
Morihiro Katsura, Hirokazu Nishina, Yasushi Shigemori & Takaya Nakanishi. (2015) Extranodal lymphoma originating in the gluteal muscle with adjacent bone involvement and mimicking a soft tissue sarcoma. International Journal of Surgery Case Reports 7, pages 161-164.
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Sally F. BarringtonN. George MikhaeelLale KostakogluMichel MeignanMartin HutchingsStefan P. MüellerLawrence H. SchwartzEmanuele ZuccaRichard I. FisherJudith TrotmanOtto S. HoekstraRodney J. HicksMichael J. O'DohertyRoland HustinxAlberto BiggiBruce D. Cheson. (2014) Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology 32:27, pages 3048-3058.
Crossref
Rosj Gallicchio, Giovanna Mansueto, Vittorio Simeon, Anna Nardelli, Roberto Guariglia, Daniela Capacchione, Ernesto Soscia, Piernicola Pedicini, Domenico Gattozzi, Pellegrino Musto & Giovanni Storto. (2014) F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. European Journal of Haematology 92:5, pages 382-389.
Crossref
B.E. Akkas & G.U. Vural. (2014) Standardized uptake value for 18F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with Diffuse Large B-Cell Lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 33:3, pages 148-152.
Crossref
B.E. Akkas & G.U. Vural. (2014) Standardized uptake value for 18F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with Diffuse Large B-Cell Lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular 33:3, pages 148-152.
Crossref
Sally Fiona Barrington & Nabegh George Mikhaeel. (2014) When should FDG-PET be used in the modern management of lymphoma?. British Journal of Haematology 164:3, pages 315-328.
Crossref
Benjamin Kasenda, Vanessa Haug, Elisabeth Schorb, Kristina Fritsch, Jürgen Finke, Michael Mix, Claudia Hader, Wolfgang A. Weber, Gerald Illerhaus & Philipp T. Meyer. (2013) 18 F-FDG PET Is an Independent Outcome Predictor in Primary Central Nervous System Lymphoma . Journal of Nuclear Medicine 54:2, pages 184-191.
Crossref
Yukihiro Miyazaki, Yuichiro Nawa, Masao Miyagawa, Sumiko Kohashi, Koichi Nakase, Masaki Yasukawa & Masamichi Hara. (2012) Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma. Annals of Hematology 92:2, pages 239-244.
Crossref
Chin-Chuan Chang, Shih-Feng Cho, Yu-Wen Chen, Hung-Pin Tu, Chia-Yang Lin & Chao-Sung Chang. (2012) SUV on Dual-Phase FDG PET/CT Correlates With the Ki-67 Proliferation Index in Patients With Newly Diagnosed Non-Hodgkin Lymphoma. Clinical Nuclear Medicine 37:8, pages e189-e195.
Crossref
Egesta Lopci, Lucia Zanoni, Arturo Chiti, Cristina Fonti, Ivan Santi, Pier Luigi Zinzani & Stefano Fanti. (2012) FDG PET/CT predictive role in follicular lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 39:5, pages 864-871.
Crossref
Yoshimi Ishii, Naoto Tomita, Seiji Sakata, Kengo Takeuchi, Ukihide Tateishi, Reina Watanabe, Rika Sakai & Yoshiaki Ishigatsubo. (2012) Maximum Standard Uptake Value at the Biopsy Site during 18 F-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict the Proliferation Potential of Tumor Cells in Extranodal Natural Killer/T Cell Lymphoma, Nasal Type . Acta Haematologica 128:2, pages 110-112.
Crossref
M.S. Hofman & R.J. Hicks. (2011) Imaging in follicular NHL. Best Practice & Research Clinical Haematology 24:2, pages 165-177.
Crossref
Ryogo Minamimoto, Miyako Morooka, Kazuo Kubota, Kimiteru Ito, Yoko Masuda-Miyata, Takuya Mitsumoto, Risen Hirai, Osamu Okazaki & Michiaki Hiroe. (2011) Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. Journal of Nuclear Cardiology 18:3, pages 516-520.
Crossref
Jose Rodriguez, Antonio Gutierrez, Antonia Obrador-Hevia, Silvia Fernandez de Mattos & Fernando Cabanillas. (2010) Therapeutic concepts in mantle cell lymphoma. European Journal of Haematology 85:5, pages 371-386.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.